BOSTON SCIENTIFIC CORP (BSX)
US1011371077 - Common Stock
Boston Scientific Takes Over #85 Spot From Lockheed Martin
Notable Tuesday Option Activity: NCLH, ETN, BSX
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the...
Noteworthy Thursday Option Activity: JPM, BSX, EPAM
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immediately. Dr....
Citi Just Raised Its Price Target on These 3 Stocks
Discover the three stocks enjoying boosted Citi price targets. Analysts believe they are primed for success, so it's time to start buying.
Needham Just Boosted Its Price Target on These 3 Stocks
Amidst the uncertainty in the market at this time, it is best to rely on Needham price targets to make informed decisions.
Boston Scientific Announces Upcoming Investor Conference Schedule
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May. On May 14, 2024, Dan Brennan, executive...
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
Wabtec Rumbles onto Stock Spotlight List. Check These Lists For Best Stocks To Watch And Buy
Wabtec leads a diverse group climbing aboard the Stock Spotlight list, including defense and aerospace play TransDigm.
BSX Stock Earnings: Boston Scientific Beats EPS, Beats Revenue for Q1 2024
BSX stock results show that Boston Scientific beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Boston Scientific Pops Into Buy Zones On Solid First-Quarter Report
Boston Scientific heads for two different buy zones after topping Q1 views and hoisting guidance above expectations.
Boston Scientific Announces Results for First Quarter 2024
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a...